Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-01-02 @ 10:39 AM
Study NCT ID:
NCT07128550
Status:
RECRUITING
Last Update Posted:
2025-11-12
First Post:
2025-08-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
Sponsor:
Vir Biotechnology, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-30
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-07
Completion Date Type:
ESTIMATED
First Submit Date:
2025-08-13
First Submit QC Date:
None
Study First Post Date:
2025-08-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-07
Last Update Post Date:
2025-11-12
Last Update Post Date Type:
ESTIMATED